The Involvement of the Gut Hormone GIP in the Pathophysiology of Post Prandial Hypotension

计划入组 18 人 · 首次发布于 2024 年 1 月 17 日

The Antiemetic Effects of Increased Splanchnic Perfusion, Induced by the Gut Hormone GIP, in Healthy Individuals

计划入组 14 人 · 首次发布于 2026 年 7 月 7 日

The Insulin Response to the Gut Hormone GIP After Near-normalisation of Plasma Glucose in Patients With Type 2 Diabetes

计划入组 15 人 · 首次发布于 2020 年 1 月 14 日

VLP-GIP

GIP-C34

Luteinizing hormone(Menopur)

LAWLEY PHARMACEUTICALS PTY LTD

Australia

Organon & Co.

United States

Context Therapeutics

United States

Merck Licenses Cancer Drug from LaNova, Tune Therapeutics Advances HBV Therapy, and Amgen Defends Obesity Drug

Lir Life Sciences Advances Needle-Free Obesity Treatment with Novel Transdermal GLP/GIP Delivery Platform

Antag Therapeutics Secures €80 Million to Advance Novel Obesity Therapy